ClinicalTrials.Veeva

Menu

Correlation of Serum Adropin to Testosterone and Adiponectin in Obese Men

A

Aswan University Hospital

Status

Completed

Conditions

Dyslipidemias
Obesity

Treatments

Diagnostic Test: Adropin
Diagnostic Test: Adiponectin
Diagnostic Test: lipid profile: Total cholesterol (TC), triglycerides (TG), low density lipoprotein (LDL) and high density lipoprotein (HDL))
Diagnostic Test: Total testosterone

Study type

Observational

Funder types

Other

Identifiers

NCT03724825
Adropin in obese men

Details and patient eligibility

About

Obesity is associated with low testosterone in men and with dyslipidemia. Adropin hormone is negatively correlated with body mass index and is associated with dyslipidemia.

correlation between adropin and testosterone will be evaluated.

Full description

Obesity, a worldwide epidemic is associated with multiple adverse health outcome as diabetes mellitus, hypertension and cardiovascular diseases caused mainly by dyslipidemia linked to obesity. Low testosterone levels in obese men were found associated with dyslipidemia.

Adropin is a new metabolic hormone that was first isolated in liver and brain tissues, It was observed that mice fed on a high-fat diet (HFD) had a rapid increase in adropin expression compared to control values. In human also, adropin levels were negatively correlated with body mass index (BMI) and were associated with dyslipidemia.

Adiponectin is a protein that is mainly produced by white adipose tissue and has an important role in lipid metabolism. Serum adiponectin concentrations were decreased in obese compared to normal weight men and significantly correlated with testosterone level.

Enrollment

82 patients

Sex

Male

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Age from 18 years to 50 years. Clinically free except from obesity

Exclusion criteria

  • Diabetes mellitus Hypertension Heart failure Kidney disease Smoking

Trial design

82 participants in 2 patient groups

obese men
Description:
Adult obese men (BMI ≥ 30 kg/m2)
Treatment:
Diagnostic Test: Adropin
Diagnostic Test: Total testosterone
Diagnostic Test: lipid profile: Total cholesterol (TC), triglycerides (TG), low density lipoprotein (LDL) and high density lipoprotein (HDL))
Diagnostic Test: Adiponectin
normal men
Description:
normal weight men (18.5 ≤ BMI \< 25 kg/m2 )
Treatment:
Diagnostic Test: Adropin
Diagnostic Test: Total testosterone
Diagnostic Test: lipid profile: Total cholesterol (TC), triglycerides (TG), low density lipoprotein (LDL) and high density lipoprotein (HDL))
Diagnostic Test: Adiponectin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems